Evidence analysisNovember 11, 2026Privacy & Data

Preparations continue for rollout of new public health surveillance platform in nine pilot countries

FreedomWitness Evidence Engine: This is an AI-assisted original analysis built from the linked source and available public source context. It separates evidence from interpretation and may challenge conventional framing only where the evidence supports it. It is not a copied article.

Privacy & Data: European Public Health Surveillance Platform Epi+ Under Preparation

This evidence dossier examines recent developments concerning a new public health surveillance platform, Epi+, scheduled for initial rollout in nine European countries in 2027. The analysis focuses on aspects relevant to data privacy and management, institutional transparency, and the broader implications for public health data use.

What is established

  • The European Centre for Disease Prevention and Control (ECDC), in collaboration with Italy’s Istituto Superiore di Sanità (ISS), is preparing to launch a new multilingual, event-based public health surveillance platform named Epi+.
  • Epi+ aims to help countries in the EU/EEA detect and assess emerging public health threats more effectively by providing enhanced tools to record and coordinate information.
  • The platform will be piloted starting June 2027 in nine countries: Croatia, Greece, Germany, Italy, Liechtenstein, Luxembourg, Portugal, Norway, and Slovenia.
  • Training sessions were held in November 2026 in Rome for 40 national epidemiologists and technical experts from these countries to facilitate the upcoming rollout.
  • Epi+ is designed to be interoperable with EpiPulse, ECDC’s existing portal for sharing epidemic signals, and its source code will be publicly accessible for national adaptation.
  • Event-based surveillance, which Epi+ supports, gathers information from a variety of sources beyond traditional routine health data, including media reports and informal signals.

What the source claims

  • ECDC states Epi+ will fill a gap since most Member States currently lack dedicated digital tools for event-based surveillance at the national level.
  • The platform is positioned as a mechanism to enhance cooperation between different national institutions involved in public health threat detection and response.
  • Training aims to build expertise enabling countries to integrate Epi+ into their existing public health surveillance frameworks.
  • The open-source nature of the platform is intended to promote adaptability and usability across various epidemiological systems.

What may be missing from the usual framing

  • The publicly available information does not elaborate on how personal data, if collected or processed by Epi+, will be managed, specifically in terms of privacy protections in compliance with regulations such as the EU General Data Protection Regulation (GDPR).
  • Details about data governance—who has access to sensitive data, how data sharing agreements are structured between national authorities, and cross-border data flow controls—are not provided.
  • The implications of integrating unstructured sources such as media reports into surveillance raise questions on data validation, potential misinformation, and impact on individuals or groups subject to reporting.
  • Legal and ethical frameworks governing the platform’s operation, particularly regarding transparency and accountability to the public, remain unspecified.
  • No mention is made of public consultation or involvement, which could influence trust and acceptance of surveillance expansion using digital tools.

Competing evidence or uncertainty

Evidence is insufficient to determine how Epi+ will specifically address privacy risk mitigation or data security challenges. The source materials emphasize technical capability and inter-agency cooperation but do not detail safeguards against potential misuse or unauthorized data access.

There is also limited information on how event-based surveillance inputs from media and informal reports will be fact-checked or balanced against privacy concerns for individuals potentially identifiable through such signals.

Different Member States may have varied national laws impacting operational use of the platform; no comparative analysis is available regarding this variability or how it might affect interoperability or data sharing.

Why it matters

  • Public health surveillance is critical for timely detection and response to infectious disease outbreaks, which this platform aims to enhance by leveraging diverse information sources and improved coordination.
  • However, expanding digital surveillance capabilities risks increased collection and centralized processing of personal or sensitive health-related data, raising privacy and civil liberties considerations.
  • How the platform balances public health benefits with protection of individual privacy rights will shape trust among citizens, health professionals, and governments.
  • Making the platform’s source code publicly available suggests a commitment to transparency and adaptability but also requires robust governance frameworks and oversight to ensure responsible use.
  • Understanding the legal and ethical guidelines underpinning Epi+ is essential to evaluate potential unintended consequences or data misuse in cross-border surveillance activities.

What to verify next

  • Specific technical and organizational measures employed by Epi+ to ensure compliance with GDPR and related data protection laws.
  • Data governance policies detailing access rights, data retention, sharing protocols, and audit mechanisms.
  • Mechanisms for validating and handling event-based surveillance data derived from non-traditional sources such as media reports.
  • Whether there have been privacy impact assessments or independent audits conducted on the platform’s design and implementation plans.
  • Public statements or documentation from participating countries regarding national adaptations, including any national legal constraints affecting platform use.
  • Engagement efforts aimed at public, civil society, or patient advocacy groups concerning the platform’s introduction and data practices.

Readers are advised to consult the original announcement by the European Centre for Disease Prevention and Control and Italy’s Istituto Superiore di Sanità for primary information and ongoing updates.

Source & verification

Primary source: News content · November 11, 2026

Read the original source

FreedomWitness links to the original source so readers can inspect the underlying material and judge the context for themselves.

Continue reading

EudraGMDP database

What is established The EudraGMDP database is an established European Union (EU) information system managed by the European Medicines Agency (EMA). It serves as…